MetLife Investment Management’s eGain EGAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,616
Closed -$26.9K 2791
2025
Q4
$26.9K Sell
2,616
-8,176
-76% -$97.7K ﹤0.01% 2768
2025
Q3
$94K Buy
+10,792
New +$74.9K ﹤0.01% 2676
2024
Q3
Sell
-5,154
Closed -$32.5K 2862
2024
Q2
$32.5K Buy
5,154
+375
+8% +$2.33K ﹤0.01% 2839
2024
Q1
$30.8K Sell
4,779
-6,462
-57% -$44.3K ﹤0.01% 2754
2023
Q4
$93.6K Hold
11,241
﹤0.01% 2637
2023
Q3
$68.9K Hold
11,241
﹤0.01% 2768
2023
Q2
$84.2K Hold
11,241
﹤0.01% 2790
2023
Q1
$85.3K Hold
11,241
﹤0.01% 2615
2022
Q4
$102K Buy
+11,241
New +$92.5K ﹤0.01% 2588
2022
Q3
Sell
-11,400
Closed -$111K 2806
2022
Q2
$111K Hold
11,400
﹤0.01% 2668
2022
Q1
$132K Buy
+11,400
New +$128K ﹤0.01% 2562
2020
Q4
Sell
-10,272
Closed -$146K 2283
2020
Q3
$146K Hold
10,272
﹤0.01% 2041
2020
Q2
$114K Buy
+10,272
New +$93.5K ﹤0.01% 2192

Other funds holding EGAN

MetLife Investment Management's EGAN Position: Q1 2026 in Review

MetLife Investment Management sold out of eGain (EGAN) in Q1 2026, closing a stake of 2,616 shares — an estimated $26.9K sold.

MetLife Investment Management first reported a position in EGAN in Q2 2020 and held it in 13 quarters. The position peaked at $146K in Q3 2020. 116 funds tracked by Wall St. Rank hold EGAN as of Q1 2026.

  • MetLife Investment Management reported no remaining eGain position as of Q1 2026 after selling out during the quarter.
  • MetLife Investment Management sold 2,616 eGain shares in Q1 2026, an estimated $26.9K.
  • MetLife Investment Management first reported a position in eGain in Q2 2020 and held it in 13 quarters.
  • MetLife Investment Management's eGain position peaked at $146K in Q3 2020.
  • 116 funds tracked by Wall St. Rank held eGain as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.